Marker Therapeutics, Inc. (MRKR)

1.73 -0.10 (-5.46%) USD  |  NASDAQ  |  Jan 13, 16:00
1.66 -0.07 (-4.05%) After-Hours: 20:00
More

Marker Therapeutics Buildings and Improvements (Quarterly)

Buildings and Improvements (Quarterly) Chart

View Buildings and Improvements (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Buildings and Improvements (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Buildings and Improvements (Quarterly) Range, Past 5 Years

View Buildings and Improvements (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Buildings and Improvements (Quarterly) Benchmarks

View Buildings and Improvements (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. --
Viridian Therapeutics, Inc. --
Neurocrine Biosciences, Inc. --
Kiniksa Pharmaceuticals International Plc --
AIM ImmunoTech, Inc. --